← All indications
Meningococcal Vaccines
Vaccines or candidate vaccines used to prevent infection with NEISSERIA MENINGITIDIS.
Drugs by status
Phase 4 trials (1)
Phase 3 trials (8)
- DTaP, inactivated poliovirus, haemophilus influenzae b conjugate, hepatitis b vaccine
- pneumococcal 13-valent conjugate vaccine
- hepatitis a vaccine, inactivated
- meningococcal (groups A, C, Y, W) tetanus toxoid conjugate vaccine
- meningococcal (group B) vaccine
- meningococcal groups a, b, c, w, and Y vaccine
- meningococcal (groups A, C, Y, W) diphtheria toxoid conjugate vaccine
- Monovalent group C meningococcal vaccine
Phase 2 trials (6)
- meningococcal (groups A, C, Y, W) CRM197 conjugate vaccine
- human papillomavirus quadrivalent (types 6, 11, 16 and 18) vaccine, recombinant
- acetaminophen
- inactivated influenza vaccine
- Diphtheria and Tetanus Toxoids and Acellular Pertussis Adsorbed and Inactivated Poliovirus Vaccine
- acellular pertussis vaccine (including diptheria and tetanus toxoids)
Other trials (1)